ICAD יתרות המזומנים של החברה iCAD, Inc.

iCAD, Inc. (ICAD) minimizes capital expenditures by utilizing the cloud infrastructure of external providers. The SaaS model for oncology diagnostics allows the business to scale easily through clinic subscriptions. The company's free cash flow reflects current liquidity trends, with the value holding at 0.02. Revenue stability is ensured by a combination of software license sales and the supply of specialized medical equipment.
פילוחים אנליטיים ודוחות נתונים של חברת iCAD, Inc. (ICAD)

This metric captures the volume of liquid assets, determining the company's ability to cover operating expenses without resorting to debt capital. By analyzing cash flow dynamics, an investor assesses the rate of spending or accumulation. The amount of cash and cash equivalents serves as a diagnostic for the business's financial autonomy. For iCAD, Inc. (ICAD), this reserve is critical when scaling SaaS subscriptions. Sufficient capital ensures the development of the ProFound AI AI platform and expansion into US oncology centers.